D
Derek A. Linkens
Researcher at University of Sheffield
Publications - 266
Citations - 5072
Derek A. Linkens is an academic researcher from University of Sheffield. The author has contributed to research in topics: Fuzzy logic & Fuzzy control system. The author has an hindex of 36, co-authored 266 publications receiving 4913 citations. Previous affiliations of Derek A. Linkens include Western Infirmary.
Papers
More filters
Journal ArticleDOI
Rule-base self-generation and simplification for data-driven fuzzy models
Min-You Chen,Derek A. Linkens +1 more
TL;DR: A rule-base self-extraction and simplification method is proposed to establish interpretable fuzzy models from numerical data and some approximate similarity measures are presented and a parameter fine-tuning mechanism is introduced to improve the accuracy of the simplified model.
Journal ArticleDOI
Survey of utilisation of fuzzy technology in medicine and healthcare
TL;DR: This paper surveys the utilisation of fuzzy logic in medical sciences, with an analysis of its possible future penetration.
Journal ArticleDOI
Genetic algorithms for fuzzy control.1. Offline system development and application
TL;DR: Genetic algorithms are used to automate and introduce objective criteria in defining fuzzy controller parameters and this paper develops the application of genetic algorithm techniques for fuzzy controller design.
Journal ArticleDOI
Learning systems in intelligent control: an appraisal of fuzzy, neural and genetic algorithm control applications
TL;DR: Parts of fuzzy logic, neural networks and genetic algorithms that pertain to realisation of intelligent control systems are reviewed, providing a compact reference for their application.
Journal ArticleDOI
Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer
David R. Yates,Ishtiaq Rehman,Maysam F. Abbod,Mark Meuth,Simon S. Cross,Derek A. Linkens,Freddie C. Hamdy,James W.F. Catto +7 more
TL;DR: Promoter hypermethylation seems a reliable predictor of tumor progression in bladder cancer and could be used to identify patients with either superficial disease requiring radical treatment or a low progression risk suitable for less intensive surveillance.